1. Home
  2. CET vs AVDL Comparison

CET vs AVDL Comparison

Compare CET & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CET
  • AVDL
  • Stock Information
  • Founded
  • CET 1929
  • AVDL 2015
  • Country
  • CET United States
  • AVDL Ireland
  • Employees
  • CET N/A
  • AVDL N/A
  • Industry
  • CET Finance/Investors Services
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • CET Finance
  • AVDL Health Care
  • Exchange
  • CET Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • CET 1.5B
  • AVDL 1.5B
  • IPO Year
  • CET N/A
  • AVDL 1996
  • Fundamental
  • Price
  • CET $51.69
  • AVDL $18.90
  • Analyst Decision
  • CET
  • AVDL Buy
  • Analyst Count
  • CET 0
  • AVDL 10
  • Target Price
  • CET N/A
  • AVDL $18.94
  • AVG Volume (30 Days)
  • CET 38.4K
  • AVDL 4.6M
  • Earning Date
  • CET 01-01-0001
  • AVDL 11-12-2025
  • Dividend Yield
  • CET 4.50%
  • AVDL N/A
  • EPS Growth
  • CET N/A
  • AVDL N/A
  • EPS
  • CET 7.40
  • AVDL N/A
  • Revenue
  • CET $27,062,484.00
  • AVDL $221,075,000.00
  • Revenue This Year
  • CET N/A
  • AVDL $64.21
  • Revenue Next Year
  • CET N/A
  • AVDL $30.80
  • P/E Ratio
  • CET $6.90
  • AVDL N/A
  • Revenue Growth
  • CET 15.78
  • AVDL 132.35
  • 52 Week Low
  • CET $40.24
  • AVDL $6.38
  • 52 Week High
  • CET $52.42
  • AVDL $18.95
  • Technical
  • Relative Strength Index (RSI)
  • CET 50.08
  • AVDL 81.47
  • Support Level
  • CET $50.26
  • AVDL $13.83
  • Resistance Level
  • CET $52.00
  • AVDL $18.65
  • Average True Range (ATR)
  • CET 0.86
  • AVDL 0.54
  • MACD
  • CET -0.03
  • AVDL 0.35
  • Stochastic Oscillator
  • CET 47.35
  • AVDL 99.02

About CET Central Securities Corporation

Central Securities Corp is a non-diversified closed-end management investment company. Its investment objective is long-term growth of capital. The company invests in common stocks, bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks, and corporations.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: